Jupiter Neurosciences Inc (JUNS)

Jan 31, 2025

Jupiter Neurosciences partners with Zina for Parkinson's trial - Investing.com India

Jan 31, 2025

Jan 30, 2025

Jupiter Neurosciences, Zina Biopharmaceuticals Collaborate on Phase 2a Parkinson's Disease Study - Marketscreener.com

Jan 30, 2025

Jan 30, 2025

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial - GlobeNewswire

Jan 30, 2025

Jan 30, 2025

Jupiter Neurosciences partners with Zina for Parkinson's trial By Investing.com - Investing.com South Africa

Jan 30, 2025

Jan 24, 2025

Wall Street Set to Open Slightly Lower Friday as Investors Await PMI, Housing Figures - TradingView

Jan 24, 2025

Jan 24, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 24, 2025

Jan 24, 2025

United States shares higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com India

Jan 24, 2025

Jan 23, 2025

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com

Jan 23, 2025

Jan 23, 2025

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com UK

Jan 23, 2025

Jan 23, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 23, 2025

Jan 23, 2025

Stock market news: Chanson International Holdings declined by 83.97% while Dogwood Therapeutics surged by 387.32% during mid day trading - Business Upturn

Jan 23, 2025

Jan 23, 2025

Stock market today: Icon Energy surged by 222.66% while Jupiter Neurosciences gained over 208.62% in early trading - Business Upturn

Jan 23, 2025

Jan 23, 2025

US Stocks Mixed; GE Aerospace Posts Upbeat Earnings - Benzinga

Jan 23, 2025

Jan 23, 2025

Modest Final Quarter Completes Shaky Biotech IPO Comeback For 2024 - News & Insights

Jan 23, 2025

Jan 22, 2025

Stock market news: Star Fashion Culture Holdings -78.42%, Lisata Therapeutics -33.08% among biggest losers in early trading - Business Upturn

Jan 22, 2025

Jan 22, 2025

Stock market today: Star Fashion Culture Holdings -79.05%, Lisata Therapeutics -23.34% among biggest losers in early trading - Business Upturn

Jan 22, 2025

Jan 14, 2025

Biopharma IPOs rebound slightly, as class of 2024 lags with a 29% average decline - BioWorld Online

Jan 14, 2025

Jan 13, 2025

Jupiter Neurosciences refocuses on NLRP3 inflammasome By Investing.com - Investing.com South Africa

Jan 13, 2025

Jan 13, 2025

Jupiter Neurosciences refocuses on NLRP3 inflammasome - Investing.com India

Jan 13, 2025

Jan 13, 2025

Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

Jupiter Neurosciences announces focus on NLRP3 pathway in JOTROL trials - TipRanks

Jan 13, 2025

Jan 13, 2025

Jupiter Neurosciences Targets NLRP3 Inflammasome With JOTROL Platform for Alzheimer's Treatment - StockTitan

Jan 13, 2025

Jan 12, 2025

Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews

Jan 12, 2025

Jan 07, 2025

December's $4.69B in biopharma financings caps a $102.15B year - BioWorld Online

Jan 07, 2025

Dec 23, 2024

Jupiter Neurosciences Inc. (JUNS) reports earnings - Quartz

Dec 23, 2024

Dec 23, 2024

Jupiter Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Dec 23, 2024

Dec 20, 2024

Jupiter Neurosciences inks deal for Southeast Asia expansion By Investing.com - Investing.com Australia

Dec 20, 2024

Dec 20, 2024

Jupiter Neurosciences inks deal for Southeast Asia expansion - Investing.com

Dec 20, 2024

Dec 20, 2024

Jupiter Neurosciences adjusts CFO compensation - Investing.com

Dec 20, 2024

Dec 19, 2024

Greenridge sees upside in Jupiter Neurosciences stock By Investing.com - Investing.com Canada

Dec 19, 2024

Dec 19, 2024

Greenridge sees upside in Jupiter Neurosciences stock - Investing.com

Dec 19, 2024

Dec 17, 2024

Finance Watch: FOPO Surge Continues With Big Offerings From Revolution, NewAmsterdam - Citeline News & Insights

Dec 17, 2024

Dec 17, 2024

Tesla, Nvidia among Tuesday's market cap stock movers - Investing.com

Dec 17, 2024

Dec 17, 2024

Tesla, Nvidia among Tuesday's market cap stock movers By Investing.com - Investing.com UK

Dec 17, 2024

Dec 17, 2024

RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 17, 2024

Dec 16, 2024

Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews

Dec 16, 2024

Dec 13, 2024

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Dec 13, 2024

Dec 13, 2024

Marvell, Credo Tech lead Friday's market cap stock movers By Investing.com - Investing.com South Africa

Dec 13, 2024

Dec 13, 2024

Marvell, Credo Tech lead Friday's market cap stock movers - Investing.com India

Dec 13, 2024

Dec 12, 2024

Adobe, Ciena lead Thursday's market cap stock movers By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 12, 2024

Adobe, Ciena lead Thursday's market cap stock movers - Investing.com

Dec 12, 2024

Dec 12, 2024

Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On ThursdayAkso Health (NASDAQ:AHG), Bloom Energy (NYSE:BE) - Benzinga

Dec 12, 2024

Dec 11, 2024

After Making the IPO Jump, Biotechs Landed On a Slippery Slope - BioSpace

Dec 11, 2024

Dec 09, 2024

Opening Day: Jinxin Technology, zSpace make public debut - MSN

Dec 09, 2024

Dec 07, 2024

U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha

Dec 07, 2024

Dec 06, 2024

IPO NewsUS IPO Weekly Recap: ServiceTitan launches as small issuers slip through the IPO window - Renaissance Capital

Dec 06, 2024

Dec 06, 2024

Rx Rundown: Eli Lilly, Amgen, GSK and more - MM+M Online

Dec 06, 2024

Dec 05, 2024

Company behind novel Parkinson's disease treatment raises $11 million in IPO - The Business Journals

Dec 05, 2024

Dec 05, 2024

Jupiter IPOs to advance resveratrol-based treatments for neuroinflammation - Longevity.Technology

Dec 05, 2024